EpiCast Report: Non-Hodgkin’s Lymphoma to 2023 - PowerPoint PPT Presentation

About This Presentation
Title:

EpiCast Report: Non-Hodgkin’s Lymphoma to 2023

Description:

Get a detailed report at . Researcher epidemiologists forecast an increase in the incident cases of B-cell NHL in the 6MM, from 89,455 incident cases in 2013 to 111,366 incident cases in 2023, with an annual growth rate (AGR) of 2.45%. In 2023, the US will have the highest number of incident cases of B-cell NHL, with 56,033 incident cases, followed by Germany with 17,176 incident cases, and the UK with 12,548 incident cases. – PowerPoint PPT presentation

Number of Views:60

less

Transcript and Presenter's Notes

Title: EpiCast Report: Non-Hodgkin’s Lymphoma to 2023


1
EpiCast Report Non-Hodgkins Lymphoma
Epidemiology Forecast to 2023
Order this report by calling 1 888 391 5441 or
Send an email to sales_at_marketoptimizer.org with
your contact details and questions if any.
  • Published May 2014
  • Single User PDF US 3995
  • Corporate User PDF US 11985

2
EpiCast Report Non-Hodgkins Lymphoma
Epidemiology Forecast to 2023
  • Non-Hodgkins lymphoma (NHL) refers to a group of
    cancers that develop in the lymphatic system. In
    NHL, the bodys immune system is affected by the
    uncontrollable growth of malignant white blood
    cells, resulting in the bodys inability to fight
    infections and other diseases. NHL is
    characterized into three types B-cell, T-cell,
    and natural killer lymphocyte lymphomas. B-cell
    lymphomas are the most common form of NHL in
    developed countries.
  • NHL ranks as the most commonly occurring
    hematologic cancer in adults. Despite the many
    advances in research, NHL remains largely
    incurable and the causes unknown.
  • Researcher epidemiologists forecast an increase
    in the incident cases of B-cell NHL in the 6MM,
    from 89,455 incident cases in 2013 to 111,366
    incident cases in 2023, with an annual growth
    rate (AGR) of 2.45.

Call Now 1 888 391 5441 Email at
sales_at_marketoptimizer.org
3
EpiCast Report Non-Hodgkins Lymphoma
Epidemiology Forecast to 2023
  • In 2023, the US will have the highest number of
    incident cases of B-cell NHL, with 56,033
    incident cases, followed by Germany with 17,176
    incident cases, and the UK with 12,548 incident
    cases.
  • For this analysis, Researcher epidemiologists
    utilized peer-reviewed journals and
    country-specific disease databases to construct
    the 10-year epidemiological forecast for the
    incident cases of follicular lymphoma, marginal
    zone lymphoma, DLBCL, and mantle cell lymphoma in
    the 6MM. A major strength of Researchers
    epidemiological analysis is the use of available
    country-specific sources, allowing for a
    meaningful comparison of the epidemiological
    characteristics of B-cell NHL in the 6MM. In
    addition, this forecast provides detailed
    segmentation of the B-cell NHL for each country
    by age, sex, and B-cell NHL subtype, thereby
    providing a comprehensive view of B-cell NHL in
    the 6MM.
  • Inquire about this report at http//www.marketopti
    mizer.org/contacts/purchase?rname5923

Call Now 1 888 391 5441 Email at
sales_at_marketoptimizer.org
4
EpiCast Report Non-Hodgkins Lymphoma
Epidemiology Forecast to 2023
  • Scope
  • The Non-Hodgkins Lymphoma (NHL) EpiCast Report
    provides an overview of the risk factors,
    comorbidities, and global and historical
    epidemiological trends for NHL in the six major
    markets (6MM) (US, France, Germany, Italy, Spain,
    and UK). It includes a 10-year epidemiological
    forecast of the incident cases of follicular
    lymphoma, marginal zone lymphoma, diffuse large
    B-cell lymphoma DLBCL, and mantle cell lymphoma
    segmented by age (ages 30 years) and sex in
    these markets.
  • The NHL epidemiology report is written and
    developed by Mastersand PhD-level
    epidemiologists.
  • The EpiCast Report is in-depth, high quality,
    transparent and market-driven, providing expert
    analysis of disease trends in the 6MM.

Call Now 1 888 391 5441 Email at
sales_at_marketoptimizer.org
5
EpiCast Report Non-Hodgkins Lymphoma
Epidemiology Forecast to 2023
  • Reasons to buy
  • Develop business strategies by understanding the
    trends shaping and driving the global NHL market.
  • Quantify patient populations in the global NHL
    market to improve product design, pricing, and
    launch plans.
  • Organize sales and marketing efforts by
    identifying the sex and age groups that present
    the best opportunities for NHL therapeutics in
    each of the markets covered.
  • Get a detailed report at http//www.marketoptimize
    r.org/epicast-report-non-hodgkins-lymphoma-epidemi
    ology-forecast-to-2023.html .

Call Now 1 888 391 5441 Email at
sales_at_marketoptimizer.org
6
EpiCast Report Non-Hodgkins Lymphoma
Epidemiology Forecast to 2023
  • About Us
  • marketoptimizer.org is an online market research
    reports library of 250,000 in-depth studies of
    over 5000 micro markets. Our database includes
    reports by leading publishers from across the
    globe. We provide 24/7 online and offline support
    service to our customers. marketoptimizer.org
    also offers company data, country profiles,
    trends, information and analysis on the sector of
    your interest.
  • Visit Us _at_
  • http//www.marketoptimizer.org
  • Follow Us

Call Now 1 888 391 5441 Email sales _at_
sales_at_marketoptimizer.org
Write a Comment
User Comments (0)
About PowerShow.com